BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Harris PS, Hansen RM, Gray ME, Massoud OI, McGuire BM, Shoreibah MG. Hepatocellular carcinoma surveillance: An evidence-based approach. World J Gastroenterol 2019; 25(13): 1550-1559 [PMID: 30983815 DOI: 10.3748/wjg.v25.i13.1550]
URL: https://www.wjgnet.com/1007-9327/full/v25/i13/1550.htm
Number Citing Articles
1
George Cholankeril, Hashem B. El-Serag. Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver DiseaseSeminars in Liver Disease 2023; 43(01): 089 doi: 10.1055/a-1957-8540
2
Imen Akkari, Hanen Jaziri. Monitoring of hepatocellular carcinomaWorld Journal of Gastroenterology 2024; 30(8): 991-993 doi: 10.3748/wjg.v30.i8.991
3
Jimmy Che-To Lai, Vicki Wing-Ki Hui, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip. Hepatocellular carcinoma surveillance after HBsAg seroclearanceExploration of Digestive Diseases 2024; : 175 doi: 10.37349/edd.2024.00046
4
Xinyi Wang, Jianyong Lei, Zhihui Li, Lunan Yan. Potential Effects of Coronaviruses on the Liver: An UpdateFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.651658
5
Shuang Jiang, Guangcong Zhang, Yanan Ma, Dongyu Wu, Da Xie, Songke Zhou, Xuemei Jiang. Ferroptosis in hepatocellular carcinoma, from mechanism to effectFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1350011
6
Zejian (Eric) Wu, Da Xu, Paul Jen-Hwa Hu, Liang Li, Ting-Shuo Huang. A meta-path, attention-based deep learning method to support hepatitis carcinoma predictions for improved cirrhosis patient managementDecision Support Systems 2024; 181: 114226 doi: 10.1016/j.dss.2024.114226
7
Omar Kamal, Natally Horvat, Sandeep Arora, Humaira Chaudhry, Mohab Elmohr, Lokesh Khanna, Pankaj Sharma Nepal, Manida Wungjramirun, Sadhna B. Nandwana, Anuradha S. Shenoy-Bhangle, James Lee, Ania Kielar, Robert Marks, Khaled Elsayes, Alice Fung. Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinomaAbdominal Radiology 2023; 48(12): 3677 doi: 10.1007/s00261-023-04033-6
8
Ya Chen, Yuan Jiang, Xinyu Huang, Lin Chen, Hao Yang, Jian Zhao, Beibei Liang, Xu Wu. Cordycepin Inhibits the Growth of Hepatocellular Carcinoma by Regulating the Pathway of Aerobic GlycolysisEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6454482
9
Min Yao, Ping Zhou, Yan-Yan Qin, Li Wang, Deng-Fu Yao. Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesisWorld Journal of Gastroenterology 2023; 29(12): 1765-1778 doi: 10.3748/wjg.v29.i12.1765
10
Xu-Sheng Zhang, Hong-Cai Zhou, Peng Wei, Long Chen, Wei-Hu Ma, Lin Ding, Shi-Cai Liang, Ben-Dong Chen. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responsesWorld Journal of Gastrointestinal Oncology 2023; 15(12): 2138-2149 doi: 10.4251/wjgo.v15.i12.2138
11
Nan Zhang, Hui Xu, A‐Hong Ren, Qian Zhang, Da‐Wei Yang, Te Ba, Zhen‐Chang Wang, Zheng‐Han Yang. Does Training in LI‐RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter‐reader Agreement in MRI Interpretation?Journal of Magnetic Resonance Imaging 2021; 54(6): 1922 doi: 10.1002/jmri.27688
12
Xiao-Fei Zhao, Ning Li, Dong-Dong Lin, Li-Bo Sun. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-AnalysisBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5353695
13
Wei Zhang, Zhong Chen, Chengjun Xue, Yao Zhang, Lipei Wu, Jichao Zhu, Shihai Xuan, Jiale Tian, Zhi Pang. The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular CarcinomaFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.740029
14
Jungnam Lee, Jong-In Chang, Young-Joo Jin, Jeong-Hoon Lee, Ju Yeon Kim, Dong Hyun Sinn, Soon Sun Kim, Hyun Woong Lee, Sun Hong Yoo, Jung Hwan Yu, Jin-Woo Lee. Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infectionEuropean Journal of Gastroenterology & Hepatology 2023; 35(4): 431 doi: 10.1097/MEG.0000000000002504
15
Afrouz Ataei, Jun Deng, Wazir Muhammad. Liver cancer risk quantification through an artificial neural network based on personal health dataActa Oncologica 2023; 62(5): 495 doi: 10.1080/0284186X.2023.2213445
16
Chuanwen Yu, Chuang Sun, Shangxiang Chen. Diagnostic Value of Multislice Spiral Computed Tomography Combined with Serum AFP, TSGF, and GP73 Assay in the Diagnosis of Primary Liver CancerEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/6581127
17
Yoshio Sumida, Masashi Yoneda, Yuya Seko, Hiroshi Ishiba, Tasuku Hara, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Hideki Hayashi, Takashi Kobayashi, Kento Imajo, Masato Yoneda, Toshifumi Tada, Takumi Kawaguchi, Yuichiro Eguchi, Satoshi Oeda, Hirokazu Takahashi, Eiichi Tomita, Takeshi Okanoue, Atsushi Nakajima. Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseDiagnostics 2020; 10(8): 579 doi: 10.3390/diagnostics10080579
18
Eva A. van Aalen, Simone F. A. Wouters, Dennis Verzijl, Maarten Merkx. Bioluminescent RAPPID Sensors for the Single-Step Detection of Soluble Axl and Multiplex Analysis of Cell Surface Cancer BiomarkersAnalytical Chemistry 2022; 94(17): 6548 doi: 10.1021/acs.analchem.2c00297
19
Claudia Maccali, Isabel V. A. Pereira, José Tadeu Stefano, Claudia P. Oliveira. Risk of Liver Cancer in MASLD: Role of Genetic Risk ScoresCurrent Hepatology Reports 2023; 22(4): 228 doi: 10.1007/s11901-023-00623-6
20
Peng Deng, Mi Li, Yuni Wu, Enas Abdulhay. The Predictive Efficacy of Serum Exosomal microRNA-122 and microRNA-148a for Hepatocellular Carcinoma Based on Smart HealthcareJournal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/5914541
21
Xiao Wang, Keyan Wang, Cuipeng Qiu, Bofei Wang, Xiaojun Zhang, Yangcheng Ma, Liping Dai, Jian-Ying Zhang. Autoantibody to GNAS in Early Detection of Hepatocellular Carcinoma: A Large-Scale Sample Study Combined with Verification in Serial Sera from HCC PatientsBiomedicines 2022; 10(1): 97 doi: 10.3390/biomedicines10010097
22
Prasanna Ramachandran, Gege Xu, Hector H. Huang, Rachel Rice, Bo Zhou, Klaus Lindpaintner, Daniel Serie. Serum Glycoprotein Markers in Nonalcoholic Steatohepatitis and Hepatocellular CarcinomaJournal of Proteome Research 2022; 21(4): 1083 doi: 10.1021/acs.jproteome.1c00965
23
L. S. Antipina, G. Ts. Dambaev, D. V. Vasilchenko, M. M. Solovev, A. P. Pisarev. Nodular hepatocellular carcinomaAnnaly khirurgicheskoy gepatologii = Annals of HPB Surgery 2023; 28(4): 88 doi: 10.16931//1995-5464.2023-4-88-92
24
Narayanan Sadagopan, Aiwu Ruth He. Recent Progress in Systemic Therapy for Advanced Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2024; 25(2): 1259 doi: 10.3390/ijms25021259
25
Hongmei Jin, Hui Wang, Guanghao Li, Qingshun Hou, Wei Wu, Fuhui Liu. Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinomaJournal of International Medical Research 2020; 48(10): 030006052096126 doi: 10.1177/0300060520961260
26
Jelena Djokic Kovac, Aleksandar Ivanovic, Tamara Milovanovic, Marjan Micev, Francesco Alessandrino, Richard M. Gore. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlationRadiology and Oncology 2021; 55(2): 130 doi: 10.2478/raon-2021-0004
27
Hua Liu, Jing Cheng, Heng Xu, Zhenzhen Wan. Lidocaine has antitumor effect on hepatocellular carcinoma via the circ_DYNC1H1/miR-520a-3p/USP14 axisOpen Life Sciences 2021; 16(1): 766 doi: 10.1515/biol-2021-0072
28
Ahila Manivannan, Samia Mazumder, Nabil Al-Kourainy. The Role of Hepatocellular Carcinoma Surveillance in Autoimmune HepatitisCureus 2020;  doi: 10.7759/cureus.11269
29
Hailey H. Choi, Stephanie Kim, Dorothy J. Shum, Chiung-Yu Huang, Amy Shui, Rena K. Fox, Mandana Khalili. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma SurveillanceRadiology: Imaging Cancer 2024; 6(1) doi: 10.1148/rycan.230118
30
Eliza W. Beal, Mackenzie Owen, Molly McNamara, Ann Scheck McAlearney, Allan Tsung. Patient-, Provider-, and System-Level Barriers to Surveillance for Hepatocellular Carcinoma in High-Risk Patients in the USA: a Scoping ReviewJournal of Gastrointestinal Cancer 2023; 54(2): 332 doi: 10.1007/s12029-022-00851-x
31
Jianlong Jia, Latai Ga, Yang Liu, Zhiyi Yang, Yue Wang, Xuanze Guo, Ruichen Ma, Ruonan Liu, Tianyou Li, Zeyao Tang, Jun Wang. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular CarcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.923031
32
Shu-Ling Chen, Chia-Ying Ho, Wei-Chun Lin, Chao-Wei Lee, Yu-Chun Chen, Jiun-Liang Chen, Hsing-Yu Chen. The Characteristics and Mortality of Chinese Herbal Medicine Users among Newly Diagnosed Inoperable Huge Hepatocellular Carcinoma (≥10 cm) Patients: A Retrospective Cohort Study with Exploration of Core HerbsInternational Journal of Environmental Research and Public Health 2022; 19(19): 12480 doi: 10.3390/ijerph191912480
33
Heinz-Peter Schlemmer. The Cancer EpidemicDie Radiologie 2023; 63(1): 49 doi: 10.1007/s00117-022-01092-6
34
Liming Zheng, Zeyu Huang, Xiaoping Li, Meifang He, Xiaoqin Liu, Guojun Zheng, Xike Zhou, Longgen Liu. Construction and validation of a predictive model for hepatocellular carcinoma based on serum markersBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02489-2
35
Shen Li, Antonio Saviano, Derek J. Erstad, Yujin Hoshida, Bryan C. Fuchs, Thomas Baumert, Kenneth K. Tanabe. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational ChallengesJournal of Clinical Medicine 2020; 9(12): 3817 doi: 10.3390/jcm9123817
36
Seung Baek Hong, Dong Hwan Kim, Sang Hyun Choi, So Yeon Kim, Ji Sung Lee, Nam Kyung Lee, Joon-Il Choi. Inadequate Ultrasound Examination in Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-AnalysisJournal of Clinical Medicine 2021; 10(16): 3535 doi: 10.3390/jcm10163535
37
Satoyoshi Yamashita, Akira Kato, Toshitaka Akatsuka, Takashi Sawada, Tomohide Asai, Noriyuki Koyama, Kiwamu Okita. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(13): 1463-1473 doi: 10.3748/wjg.v26.i13.1463
38
Wenjie Xu, Shuyi Liu, Genshan Zhang, Jin Liu, Gang Cao. Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cellsJournal of Chemotherapy 2023; 35(5): 455 doi: 10.1080/1120009X.2022.2143614
39
Gehad Ahmad Saleh, Ahmed Abdel Khalek Abdel Razek, Lamiaa Galal El-Serougy, Walaa Shabana, Rihame Abd El-Wahab. The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System version 2018Polish Journal of Radiology 2022; 87: 43 doi: 10.5114/pjr.2022.113193
40
Atsushi Kudo, Masahiro Shinoda, Shunichi Ariizumi, Takafumi Kumamoto, Masafumi Katayama, Takehito Otsubo, Itaru Endo, Yuko Kitagawa, Minoru Tanabe, Masakazu Yamamoto. Des-gamma-carboxy prothrombin affects the survival of HCC patients with marginal liver function and curative treatment: ACRoS1402Journal of Cancer Research and Clinical Oncology 2020; 146(11): 2949 doi: 10.1007/s00432-020-03270-2
41
C.A. Marschner, L. Zhang, V. Schwarze, W. Völckers, M.F. Froelich, N. von Münchhausen, M.L. Schnitzer, T. Geyer, M.P. Fabritius, J. Rübenthaler, D.-A. Clevert. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1Clinical Hemorheology and Microcirculation 2021; 76(4): 453 doi: 10.3233/CH-209221
42
Wenhao Li, Polychronis Kemos, Justin D. Salciccioli, Dominic C. Marshall, Joseph Shalhoub, William Alazawi. Socioeconomic Factors Associated With Liver-Related Mortality From 1985 to 2015 in 36 Developed CountriesClinical Gastroenterology and Hepatology 2021; 19(8): 1698 doi: 10.1016/j.cgh.2020.08.047
43
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosisAcademic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
44
Dongyang Wu, Qingshan Cai, Dong Liu, Ganggang Zuo, Shudong Li, Liyou Liu, Jianxing Zheng. Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma: A reviewMedicine 2023; 102(10): e33228 doi: 10.1097/MD.0000000000033228
45
Doha M. AbdElaleem, Safia M. Mohammed, Olfat M. Hendy, Neamat A. Abdelmageed. Serum midkine level as a diagnostic biomarker of hepatocellular carcinoma in Egyptian patients with chronic hepatitis CThe Scientific Journal of Al-Azhar Medical Faculty, Girls 2022; 6(1): 75 doi: 10.4103/sjamf.sjamf_216_21
46
Hengdong Qu, Junli Liu, Di Zhang, Ruoyan Xie, Lijuan Wang, Jian Hong. Glycolysis in Chronic Liver Diseases: Mechanistic Insights and Therapeutic OpportunitiesCells 2023; 12(15): 1930 doi: 10.3390/cells12151930
47
Daryl Ramai, Jameel Singh, Saurabh Chandan, Nicola Tartaglia, Antonio Ambrosi, Shahab R. Khan, Rodolfo Sacco, Antonio Facciorusso. Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With CirrhosisJournal of Clinical Gastroenterology 2023; 57(2): 198 doi: 10.1097/MCG.0000000000001668
48
Shiyue Zhou, Zixuan Zhao, Hao Zhong, Zehao Ren, Yuye Li, Hong Wang, Yuling Qiu. The role of myeloid-derived suppressor cells in liver cancerDiscover Oncology 2023; 14(1) doi: 10.1007/s12672-023-00681-8
49
V. V. Breder, R. B. Alikhanov, S. S. Bagnenko, E. N. Bessonova, V. A. Isakov, N. E. Kudashkin, B. M. Medvedeva, A. V. Mishchenko, M. S. Novruzbekov, V. S.  Rudakov. Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert PanelRussian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 32(5): 16 doi: 10.22416/1382-4376-2022-32-5-16-23
50
Rong Fan, George Papatheodoridis, Jian Sun, Hamish Innes, Hidenori Toyoda, Qing Xie, Shuyuan Mo, Vana Sypsa, Indra Neil Guha, Takashi Kumada, Junqi Niu, George Dalekos, Satoshi Yasuda, Eleanor Barnes, Jianqi Lian, Vithika Suri, Ramazan Idilman, Stephen T. Barclay, Xiaoguang Dou, Thomas Berg, Peter C. Hayes, John F. Flaherty, Yuanping Zhou, Zhengang Zhang, Maria Buti, Sharon J. Hutchinson, Yabing Guo, Jose Luis Calleja, Lanjia Lin, Longfeng Zhao, Yongpeng Chen, Harry L.A. Janssen, Chaonan Zhu, Lei Shi, Xiaoping Tang, Anuj Gaggar, Lai Wei, Jidong Jia, William L. Irving, Philip J. Johnson, Pietro Lampertico, Jinlin Hou. aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisJournal of Hepatology 2020; 73(6): 1368 doi: 10.1016/j.jhep.2020.07.025
51
Puo-Hsien Le, Chia-Jung Kuo, Yi-Chung Hsieh, Tsung-Hsing Chen, Chih-Lang Lin, Chau-Ting Yeh, Kung-Hao Liang. Ages of hepatocellular carcinoma occurrence and life expectancy are associated with a UGT2B28 genomic variationBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6409-3
52
Lei Zhao, Houbin Zhang, Peiyou Ren, Xiangjun Sun. LncRNA SLC9A3-AS1 knockdown increases the sensitivity of liver cancer cell to triptolide by regulating miR-449b-5p-mediated glycolysisBiotechnology and Genetic Engineering Reviews 2023; : 1 doi: 10.1080/02648725.2023.2193775
53
Raphaël Girardet, Margaux Dubois, Gibran Manasseh, Mario Jreige, Céline Du Pasquier, Emma Canniff, Marianna Gulizia, Melissa Bonvin, Yasser Aleman, Bachir Taouli, Montserrat Fraga, Clarisse Dromain, Naik Vietti Violi. The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screeningEuropean Radiology 2023; 33(10): 6929 doi: 10.1007/s00330-023-09906-4
54
Paul Smereka, Ankur M. Doshi, Lisa P. Lavelle, Krishna Shanbhogue. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS ClassificationAmerican Journal of Roentgenology 2020; 215(2): 382 doi: 10.2214/AJR.19.22033
55
Guangxin Yan, Zhihui Chang, Chuanzhuo Wang, Zheng Gong, He Xin, Zhaoyu Liu. LncRNA ILF3-AS1 promotes cell migration, invasion and EMT process in hepatocellular carcinoma via the miR-628–5p/MEIS2 axis to activate the Notch pathwayDigestive and Liver Disease 2022; 54(1): 125 doi: 10.1016/j.dld.2021.04.036
56
Yukihiro Shirota, Yoshimichi Ueda, Katsuaki Sato, Yasuhito Takeda, Yuji Hodo, Tokio Wakabayashi. Solitary extrahepatic hepatocellular carcinoma in vertebrae without a primary lesion in the liver might originate from bone marrow: a case report and new hypothesis based on a review of the literature and the latest findingsClinical Journal of Gastroenterology 2022; 15(6): 1115 doi: 10.1007/s12328-022-01701-w
57
Joshua P Kronenfeld, Neha Goel. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2021; : 1209 doi: 10.2147/JHC.S284430
58
Jiaoxia He, Zhongling Zheng, Tingting Liu, Yupei Ao, Yixuan Yang, Huaidong Hu. Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18894-2
59
Luwen Xing, Yiwen Zhang, Saiyu Li, Minghui Tong, Kaishun Bi, Qian Zhang, Qing Li. A Dual Coverage Monitoring of the Bile Acids Profile in the Liver–Gut Axis throughout the Whole Inflammation-Cancer Transformation Progressive: Reveal Hepatocellular Carcinoma PathogenesisInternational Journal of Molecular Sciences 2023; 24(5): 4258 doi: 10.3390/ijms24054258
60
Ashraf Khalil, Ashraf Elfert, Samar Ghanem, Marwa Helal, Shymaa Abdelsattar, Gamalate Elgedawy, Manar Obada, Mohamed Abdel-Samiee, Hala El-Said. The role of metabolomics in hepatocellular carcinomaEgyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00085-9
61
Yuanlin Zou, Jicun Zhu, Caijuan Song, Tiandong Li, Keyan Wang, Jianxiang Shi, Hua Ye, Peng Wang. A polygenetic risk score combined with environmental factors better predict susceptibility to hepatocellular carcinoma in Chinese populationCancer Medicine 2024; 13(9) doi: 10.1002/cam4.7230
62
Raoul C Reulen, Kwok F Wong, Chloe J Bright, David L Winter, Daniela Alessi, Rodrigue M Allodji, Francesca Bagnasco, Edit Bárdi, Andrea Bautz, Julianne Byrne, Elizabeth AM Feijen, Miranda M Fidler-Benaoudia, Ibrahim Diallo, Stanislaw Garwicz, Desiree Grabow, Thorgerdur Gudmundsdottir, Joyeeta Guha, Nadia Haddy, Stine Høgsholt, Moncilo Jankovic, Peter Kaatsch, Melanie Kaiser, Rahel Kuonen, Helena Linge, Hilde Øfstaas, Cecile M Ronckers, Eva-Maria Hau, Roderick Skinner, Flora E van Leeuwen, Jop C Teepen, Cristina Veres, Wael Zrafi, Ghazi Debiche, Damien Llanas, Monica Terenziani, Giao Vu-Bezin, Finn Wesenberg, Thomas Wiebe, Carlotta Sacerdote, Zsuzsanna Jakab, Riccardo Haupt, Päivi M Lähteenmäki, Lorna Zadravec Zaletel, Claudia E Kuehni, Jeanette F Winther, Florent de Vathaire, Leontien C Kremer, Lars Hjorth, Michael M Hawkins. Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup studyGut 2021; 70(8): 1520 doi: 10.1136/gutjnl-2020-322237
63
Yue Li, Shou-Li Yuan, Jing-Ya Yin, Kun Yang, Xin-Gang Zhou, Wen Xie, Qi Wang. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysisWorld Journal of Gastrointestinal Oncology 2022; 14(7): 1265-1280 doi: 10.4251/wjgo.v14.i7.1265
64
Yue Cai, Deng Wu, Lei Zhan. CCT6A expression in hepatocellular carcinoma and its correlation with clinical characteristics, liver function indexes, tumor markers and prognosisClinics and Research in Hepatology and Gastroenterology 2022; 46(3): 101796 doi: 10.1016/j.clinre.2021.101796
65
Zhuo Wang, Aishi Wang, Qiao Liu, Shuanglian Wang, Xuantao Su, Valery V. Tuchin, Qingming Luo, Lihong V. Wang. Label-free analysis of single microparticles and nanoscale exosomes with two-dimensional light scattering technologySixteenth International Conference on Photonics and Imaging in Biology and Medicine (PIBM 2023) 2023; : 15 doi: 10.1117/12.2682909
66
Pengfei Ren, Keyan Wang, Jie Ma, Xiaoqin Cao, Jiuzhou Zhao, Chengzhi Zhao, Yongjun Guo, Hua Ye. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver CancerJournal of Hepatocellular Carcinoma 2022; : 221 doi: 10.2147/JHC.S352057
67
Nathan Bryan, Arash Zandieh, Bhaskar Kallakury, Stuart Kaufman, Nada Yazigi, Rafaele Girlanda, Jason Hawksworth, Thomas Fishbein, Cal Matsumoto, Alexander Kroemer, Khalid Khan. De novo hepatocellular carcinoma 18 years after liver and small bowel transplantation in a one‐year‐old pediatric patientPediatric Transplantation 2021; 25(2) doi: 10.1111/petr.13820
68
Mohammad Golriz, Ali Ramouz, Sadeq Ali-Hasan-Al-Saegh, Saeed Shafiei, Ehsan Aminizadeh, Ahmed Hammad, Markus Mieth, Christian Rupp, Christoph Springfeld, Katrin Hoffmann, Markus Büchler, Arianeb Mehrabi. Prognostic Value of Red Blood Cell Distribution Width (RDW) in the Recurrence of Hepatocellular Carcinoma Following Curative ResectionJournal of Hepatocellular Carcinoma 2022; : 1137 doi: 10.2147/JHC.S380243
69
Hideki Fujii, Hiroyuki Kimura, Chitomi Hasebe, Takehiro Akahane, Takashi Satou, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Hiroyuki Marusawa, Haruhiko Kobashi, Keiji Tsuji, Chikara Ogawa, Yasushi Uchida, Kouji Joko, Akeri Mitsuda, Masayuki Kurosaki, Namiki Izumi. Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infectionJGH Open 2022; 6(5): 344 doi: 10.1002/jgh3.12749
70
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu, Yunfu Cui. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204715
71
Huan Deng, Xiude Fan, Xiaoyun Wang, Lu Zeng, Kun Zhang, Xiaoge Zhang, Na Li, Qunying Han, Yi Lv, Zhengwen Liu. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infectionScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77332-3
72
Christina C. Köpping-Segerling, Michael Pohl, Ali Canbay, Jan Best. Hepatozelluläres Karzinom – Screening und SurveillanceDie Gastroenterologie 2022; 17(6): 387 doi: 10.1007/s11377-022-00651-6
73
Min Yang, Huiqin Zhang, Jieqiu Zhang, Xiaopeng Yao. Risk factors and prevention of liver cancer: A bibliometric and visual analysisMedicine 2023; 102(47): e35740 doi: 10.1097/MD.0000000000035740
74
Raquel Ríos León, Eugenia Sánchez Rodríguez , Antonio Martínez Ortega, Enrique Rodríguez de Santiago, Natalia Marcos Carrasco, Javier Graus Morales, Miguel Ángel Rodríguez Gandía, Jose Luis Lledó Navarro, Francisco Gea Rodríguez, Javier María Nuño Vázquez Garza, Agustín Albillos Martínez, Miguel García González . Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort studyRevista Española de Enfermedades Digestivas 2021;  doi: 10.17235/reed.2021.7744/2020
75
Yasuyuki Tamai, Motoh Iwasa, Akiko Eguchi, Ryuta Shigefuku, Ryosuke Sugimoto, Hideaki Tanaka, Yoshinao Kobayashi, Shugo Mizuno, Hayato Nakagawa. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatmentEuropean Journal of Gastroenterology & Hepatology 2022; 34(12): 1269 doi: 10.1097/MEG.0000000000002459
76
Xiangyu Kong, Zhen He, Zhaohua Ji, Ting Fu, Xiaojie Yuan, Haowei Zhou, Zhongjun Shao, Weilu Zhang. A Circulating MicroRNA-375 for the Detection of Liver Cancer: A Meta-AnalysisGenetic Testing and Molecular Biomarkers 2022; 26(12): 564 doi: 10.1089/gtmb.2022.0128
77
Dattatrya Shetti, Venkata Ramana Mallela, Wenjing Ye, Mahyar Sharif, Filip Ambrozkiewicz, Andriy Trailin, Václav Liška, Kari Hemminki. Emerging Role of Circulating Cell-Free RNA as a Non-Invasive Biomarker for Hepatocellular CarcinomaCritical Reviews in Oncology/Hematology 2024; : 104391 doi: 10.1016/j.critrevonc.2024.104391
78
Qisthina Syifa Setiawan, Zuherman Rustam, Sri Hartini, Afifah Rofi Laeli, Ilsya Wirasati. Comparison of Naive Bayes and Decision Tree for Classifying Hepatocellular Carcinoma (HCC)2020 International Conference on Innovation and Intelligence for Informatics, Computing and Technologies (3ICT) 2020; : 1 doi: 10.1109/3ICT51146.2020.9312022
79
Qian Ding, Dongdong Lin, Yajing Zhou, Feng Li, Jianming  Lai, Jianping Duan, Jing Chen, Caihua Jiang. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL‑6/JAK/STAT3 pathway activation in hepatocellular carcinomaOncology Letters 2021; 22(6) doi: 10.3892/ol.2021.13118
80
Xianyu Chen, Yongsheng Tang, Donghao Wu, Ruixi Li, Zhiqun Lin, Xuhui Zhou, Hezhen Wang, Hang Zhai, Junming Xu, Xianjie Shi, Guangquan Zhang. From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1278467
81
Thitiporn Pathomjaruwat, Yaowarat Matchim, Jane M. Armer. Symptoms and symptom clusters in patients with hepatocellular carcinoma and commonly used instruments: An integrated reviewInternational Journal of Nursing Sciences 2023;  doi: 10.1016/j.ijnss.2023.09.009
82
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art ReviewDiagnostics 2023; 13(4): 625 doi: 10.3390/diagnostics13040625
83
Zhuolin Li, Yao Lin, Bizhen Cheng, Qiaoxin Zhang, Yingmu Cai. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics MethodsFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.571231
84
Averill Guo, Sydney Pomenti, Julia Wattacheril. Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular CarcinomaClinical Liver Disease 2021; 17(5): 353 doi: 10.1002/cld.1057
85
Kelly Casler, Amanda Chaney. CirrhosisThe Nurse Practitioner 2020; 45(8): 16 doi: 10.1097/01.NPR.0000681772.39310.d0
86
Yuemin Nan, Osvaldo Ulises Garay, Xianzhong Lu, Yue Zhang, Li Xie, Zhongyi Niu, Wen Chen. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysisJournal of Comparative Effectiveness Research 2024; 13(4) doi: 10.57264/cer-2023-0146
87
Chuanzong Zhao, Ben Wang, Enyu Liu, Zongli Zhang. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinomaCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00622-w
88
Thais Maloberti, Antonio De Leo, Viviana Sanza, Elisa Gruppioni, Annalisa Altimari, Mattia Riefolo, Michela Visani, Deborah Malvi, Antonia D’Errico, Giovanni Tallini, Francesco Vasuri, Dario de Biase. Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian centerWorld Journal of Gastroenterology 2022; 28(25): 2854-2866 doi: 10.3748/wjg.v28.i25.2854
89
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa regionLiver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
90
Philip J. Johnson, Ehsan Bhatti, Hidenori Toyoda, Shan He. Serologic Detection of Hepatocellular Carcinoma: Application of Machine Learning and Implications for Diagnostic ModelsJCO Clinical Cancer Informatics 2024; (8) doi: 10.1200/CCI.23.00199
91
Zhiwen Lai, Tianning Wei, Qingming Li, Xianglong Wang, Yang Zhang, Shengliang Zhang. Exosomal circFBLIM1 Promotes Hepatocellular Carcinoma Progression and Glycolysis by Regulating the miR-338/LRP6 AxisCancer Biotherapy and Radiopharmaceuticals 2023; 38(10): 674 doi: 10.1089/cbr.2020.3564
92
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver and COVID-19: From care of patients with liver diseases to liver injuryWorld Journal of Hepatology 2021; 13(10): 1367-1377 doi: 10.4254/wjh.v13.i10.1367
93
Ryan Alberts, AnnMarie Zimmermann, Anthony Martinez. Improving hepatitis C screening and access to treatmentJAAPA 2022; 35(10): 17 doi: 10.1097/01.JAA.0000873784.48761.b2
94
Andrew McDonald, Chen Dai, Qingrui Meng, Lindsey Hageman, Joshua Richman, Jessica Wu, Liton Francisco, Elizabeth Ross, Nora Balas, Alysia Bosworth, Hok Sreng Te, F. Lennie Wong, Wendy Landier, Donna Salzman, Ravi Bhatia, Daniel J. Weisdorf, Stephen J. Forman, Saro H. Armenian, Smita Bhatia. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow TransplantJAMA Oncology 2023; 9(3): 376 doi: 10.1001/jamaoncol.2022.6569
95
Shiqi Hu, Yaqin Liu, Qidong Yang, Lin Chen, Huizi Chai, Mingzhe Xiao, Chuang Qi, Wei Qiu. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinomaInvestigational New Drugs 2023; 41(3): 532 doi: 10.1007/s10637-023-01363-6
96
A. S. Shkaraburov, D. N. Rudenko, E. F. Vaiman, O. M. Soboleva, Yu. V. Zakharova. Asymptomatic Hepatocellular Carcinoma (Clinical Case)Creative surgery and oncology 2022; 12(3): 256 doi: 10.24060/2076-3093-2022-12-3-256-260
97
Gehad A. Saleh, Ali H. Elmokadem, Ahmed Abdel Razek, Ahmed El-Morsy, Omar Hamdy, Elshimaa S. Eleraky, Marwa Saleh. Utility of diffusion tensor imaging in differentiating benign from malignant hepatic focal lesionsEuropean Radiology 2022; 33(2): 1400 doi: 10.1007/s00330-022-09091-w
98
Emily Truong, Cheng Han, Mark Muthiah, Mazen Noureddin. Risk Stratification for Hepatocellular Carcinoma in Patients with Non-alcoholic Fatty Liver DiseaseCurrent Hepatology Reports 2023; 22(1): 1 doi: 10.1007/s11901-023-00595-7
99
Hao Cui, Ye Qi, Chunyue Guo, Naijun Tang. The effect of PM2.5 exposure on the mortality of patients with hepatocellular carcinoma in Tianjin, ChinaEnvironmental Science and Pollution Research 2023; 30(32): 78632 doi: 10.1007/s11356-023-28039-1
100
Lauren J. McEneaney, Mathew Vithayathil, Shahid Khan. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e2024; : 271 doi: 10.1002/9781119756422.ch16
101
Ashraf Omar, Ahmed Kaseb, Tamer Elbaz, Mohamed El-Kassas, Amr El Fouly, Abdel Fatah Hanno, Ahmed El Dorry, Ahmed Hosni, Amr Helmy, Amr S Saad, Ashwaq Alolayan, Basem Eysa, Emad Hamada, Hamdy Azim, Hany Khattab, Hesham Elghazaly, Hesham Tawfik, Hisham Ayoub, Hussein Khaled, Ibtessam Saadeldin, Imam Waked, Eman Barakat, Mahmoud El Meteini, Mohamed Hamed Shaaban, Mohamed EzzElarab, Mohamed Fathy, Mohamed Shaker, Mohamed Sobhi, Mohamed Shaker, Mohamed ElGharib, Mohammed Abdullah, Mohesn Mokhtar, Mostafa Elshazli, Omar Heikal, Osama Hetta, Reda ElWakil, Sameh Abdel Wahab, Samir Eid, Yousri Rostom. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2023; : 1547 doi: 10.2147/JHC.S404424
102
Alexander Villalobos, William Wagstaff, Mian Guo, James Zhang, Zachary Bercu, Morgan J. Whitmore, Mircea M Cristescu, Bill S. Majdalany, Joel Wedd, Mehmet Akce, Joseph Magliocca, Marty T. Sellers, Nima Kokabi, Alessandro Granito. Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular CarcinomaCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/9926704
103
Qinfan Yao, Xiuyuan Zhang, Dajin Chen. Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human DiseasesFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.848296
104
Yungang Zhu, Baoguo Li, Guoping Xu, Changrui Han, Gang Xing. lncRNA MIR4435‑2HG promotes the progression of liver cancer by upregulating B3GNT5 expressionMolecular Medicine Reports 2021; 25(1) doi: 10.3892/mmr.2021.12554
105
Hanchuan Tao, Cheng Wang, Chongmei Lu, Ning Ma, Yifan Zhu, Shihai Xuan, Xiaojun Zhou, Yaying Sun. Comprehensive Analysis on the Specific Role and Function of Mitochondrial Inner Membrane Protein MPV17 in Liver Hepatocellular CarcinomaGenetics Research 2022; 2022: 1 doi: 10.1155/2022/7236823
106
Aisling Barry, Smith Apisarnthanarax, Grainne M O'Kane, Gonzalo Sapisochin, Robert Beecroft, Riad Salem, Sang Min Yoon, Young-Suk Lim, John Bridgewater, Brian Davidson, Marta Scorsetti, Luigi Solbiati, Adam Diehl, Pablo Munoz Schuffenegger, Jonathan G Sham, David Cavallucci, Zita Galvin, Laura A Dawson, Maria A Hawkins. Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspectiveThe Lancet Gastroenterology & Hepatology 2020; 5(8): 765 doi: 10.1016/S2468-1253(20)30182-5
107
Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li. Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in ChinaInternational Journal of Clinical Pharmacy 2024; 46(2): 429 doi: 10.1007/s11096-023-01675-w
108
Mingming Fei, Xianying Li, Shuhang Liang, Shuo Zhou, Huihui Wu, Linmao Sun, Yao Liu, Qingsong Hu, Lianxin Liu, Jiabei Wang. LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activityCancer Letters 2024; 584: 216620 doi: 10.1016/j.canlet.2024.216620
109
Nicole C. Panarelli. Frozen Section Pathology2021; : 49 doi: 10.1007/978-3-030-71308-9_4
110
Bo Li, Youyun Zhao, Wangxi Cai, Anping Ming, Hanmin Li. Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinomaClinical Proteomics 2021; 18(1) doi: 10.1186/s12014-021-09326-w
111
Ulfa Kholili, Alvin Hartanto Kurniawan, Choirina Winda, Ummi Maimunah, Poernomo Budi Setiawan. The Role of Metformin as Chemopreventive Strategies for Hepatocellular CarcinomaResearch Journal of Pharmacy and Technology 2023; : 377 doi: 10.52711/0974-360X.2023.00065
112
Olayinka Fisayo Onifade, Oluseyi Adeboye Akinloye, Oluwatosin A. Dosumu, Abdul Lateef Aderemi Shotuyo. In silico and in vivo anti-angiogenic validation on ethanolic extract of Curcuma longa and curcumin compound in hepatocellular carcinoma through mitogen activated protein kinase expression in male and female wistar ratsFood and Chemical Toxicology 2023; 182: 114096 doi: 10.1016/j.fct.2023.114096
113
Joshua P. Kronenfeld, Emily L. Ryon, David Goldberg, Rachel M. Lee, Adam Yopp, Annie Wang, Ann Y. Lee, Sommer Luu, Cary Hsu, Eric Silberfein, Maria C. Russell, Alan S. Livingstone, Nipun B. Merchant, Neha Goel. Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative StudyAnnals of Surgical Oncology 2021; 28(4): 1929 doi: 10.1245/s10434-020-09156-4
114
Ahmed Haitham Abduljabbar. Diagnostic accuracy of ultrasound and alpha-fetoprotein measurement for hepatocellular carcinoma surveillance: a retrospective comparative studyEgyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-00982-6
115
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver DiseaseCancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
116
Kelly Casler, Amanda Chaney. CirrhosisNursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
117
Yi-Ming Qi, En-Hua Xiao. Advances in application of novel magnetic resonance imaging technologies in liver disease diagnosisWorld Journal of Gastroenterology 2023; 29(28): 4384-4396 doi: 10.3748/wjg.v29.i28.4384
118
Sobia Zaidi, Richard Amdur, Xiyan Xiang, Herbert Yu, Linda L. Wong, Shuyun Rao, Aiwu R. He, Karan Amin, Daewa Zaheer, Raj K. Narayan, Sanjaya K. Satapathy, Patricia S. Latham, Kirti Shetty, Chandan Guha, Nancy R. Gough, Lopa Mishra. Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancerGenes & Cancer 2022; 13: 9 doi: 10.18632/genesandcancer.220
119
Hui Li, Yan Wang, Shizhao Ma, Chaoqun Zhang, Hua Liu, Dianxing Sun. Clinical significance of small molecule metabolites in the blood of patients with different types of liver injuryScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91164-9
120
Young S. Rho, Ian Pagano, Linda L. Wong, Sandi A. Kwee, Jared D. Acoba. Factors and Survival Implications associated with biopsy of hepatocellular carcinomaHPB 2021; 23(7): 1054 doi: 10.1016/j.hpb.2020.11.001
121
Masayuki Ueno, Haruhiko Takeda, Atsushi Takai, Hiroshi Seno. Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectivesWorld Journal of Gastroenterology 2022; 28(27): 3410-3421 doi: 10.3748/wjg.v28.i27.3410
122
Mounika Kanneganti, Jorge A. Marrero, Neehar D. Parikh, Fasiha Kanwal, Takeshi Yokoo, Mishal Mendiratta‐Lala, Nicole E. Rich, Purva Gopal, Amit G. Singal. Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic reviewLiver Transplantation 2022; 28(12): 1865 doi: 10.1002/lt.26562
123
Cody Criss, Arpit M Nagar, Mina S Makary. Hepatocellular carcinoma: State of the art diagnostic imagingWorld Journal of Radiology 2023; 15(3): 56-68 doi: 10.4329/wjr.v15.i3.56
124
Han Li, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li. Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysisExpert Review of Gastroenterology & Hepatology 2023; 17(11): 1159 doi: 10.1080/17474124.2023.2279175
125
Delfino Y Li, Trang VoPham, Mei-Tzu C Tang, Christopher I Li. Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and EthnicityJNCI: Journal of the National Cancer Institute 2022; 114(9): 1238 doi: 10.1093/jnci/djac097
126
Felix Lu, Connor Ott, Prabha Bista, Xuanyong Lu. Three-Dimensional Structure of Novel Liver Cancer Biomarker Liver Cancer-Specific Serine Protease Inhibitor Kazal (LC-SPIK) and Its Performance in Clinical Diagnosis of Hepatocellular Carcinoma (HCC)Diagnostics 2024; 14(7): 725 doi: 10.3390/diagnostics14070725
127
Priscila Henriques da Silva, Matheus Menezes Gomes, Carla Adriana Loureiro de Matos, Ivonete Sandra de Souza e Silva, Adriano Miziara Gonzalez, Ulysses S. Torres, Gloria Maria Martinez Salazar, Giuseppe D'Ippolito. HCC Detection on Surveillance USJournal of Ultrasound in Medicine 2021; 40(11): 2487 doi: 10.1002/jum.15637
128
Qimeng Chang, Yayun Xu, Jianfa Wang, Hui Jing, Longhua Rao, Weiguo Tang, Ziping Zhang, Xubo Wu, Jianxin Shi. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular CarcinomaComputational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/8556888
129
Christos Damaskos, Nikolaos Garmpis, Dimitrios Dimitroulis, Anna Garmpi, Iason Psilopatis, Panagiotis Sarantis, Evangelos Koustas, Prodromos Kanavidis, Dionysios Prevezanos, Gregory Kouraklis, Michail V. Karamouzis, Georgios Marinos, Konstantinos Kontzoglou, Efstathios A. Antoniou. Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead—A Systematic ReviewInternational Journal of Molecular Sciences 2022; 23(22): 14117 doi: 10.3390/ijms232214117
130
Yun Bai, Dan Lu, Di Qu, Yiwen Li, Ning Zhao, Guanghua Cui, Xue Li, Xiaoke Sun, Yanying Liu, Meiqi Wei, Yu Yang, Zhongjie Shi. The Role of ANGPTL Gene Family Members in Hepatocellular CarcinomaDisease Markers 2022; 2022: 1 doi: 10.1155/2022/1844352